Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Yoshi Itoh Dupuytren's award
Yoshi Itoh (r) receives the International Dupuytren award 2022 from Dominic Furniss (l)

Yoshi's paper: “A common SNP risk variant MT1-MMP causative for Dupuytren’s disease has a specific defect in collagenolytic activity”, published in Matrix Biology was recognised as the best paper published on the subject of Dupuytren's Disease in the previous year.

On receiving the award Yoshi said: “It is wonderful that our discovery was recognised by the International Dupuytren Society. I feel very honoured to receive the International Dupuytren's Award 2022. Our study demonstrated that one of the causes of Dupuytren disease is the impaired collagen catabolism caused by the single nucleotide polymorphism at the gene of the crucial cell surface collagenolytic enzyme, MT1-MMP/MMP-14. We hope that our discovery will lead to the development of novel therapeutics for Dupuytren disease in the future.

"Around 30% of the worldwide population or 35% of the European population have the low collagenolytic SNP allele. Therefore, further investigation on the impact of the SNP in different pathophysiological conditions is very important. Finally, I wish to express my appreciation to all the authors of the paper. Without everyones’ contributions, it would have been impossible to complete the paper.”

Professor Dominic Furniss, who presented Yoshi with the award said: “My congratulations go to Yoshi for this recognition of his research by the International Dupuytren Society. This is the sixth year running that a team from NDORMS has won the award, which demonstrates our world leading research in this area.”

The International Dupuytren Award recognises exceptional scientific publications on research or clinical treatment of Dupuytren and/or Ledderhose disease. 

Similar stories

NIHR Fellowships awarded to NDORMS researchers

Congratulations to Eileen Morrow and Mae Chester-Jones who have received NIHR Doctoral Fellowships

ORUK Early Career Research Fellowship awarded to NDORMS researcher

Congratulations to Jack Tu who has been awarded an Orthopaedic Research UK Early Career Research Fellowship to explore the cause of knee pain after total knee replacement.

OCTRU - delivering answers to important clinical questions

The Oxford Clinical Trials Research Unit (OCTRU) has received NIHR benchmarking results and offers excellent value for money according to the report

Unhelpful thoughts about fracture symptoms hinder recovery

The importance of mindsets and feelings about fracture symptoms have been shown to be a key factor in recovery of musculoskeletal conditions.

Fat tissues can play a protective role against inflammation in the intestine

A new study in The EMBO Journal has revealed how fat tissues might provide a protective role in intestinal inflammation opening new lines of research into the treatment of inflammatory bowel diseases.

NDORMS researchers awarded Sir Henry Wellcome Fellowships

Kennedy Institute researchers Mariana Borsa and Edward Jenkins have both been awarded Sir Henry Wellcome Postdoctoral Fellowships, which give recently qualified postdoctoral researchers the opportunity to start independent research careers.